M&A Deal Summary

Abiomed Acquires Impella CardioSystems AG

On April 27, 2005, Abiomed acquired medical products company Impella CardioSystems AG

Acquisition Highlights
  • This is Abiomed’s 1st transaction in the Medical Products sector.
  • This is Abiomed’s 1st transaction in Germany.

M&A Deal Summary

Date 2005-04-27
Target Impella CardioSystems AG
Sector Medical Products
Buyer(s) Abiomed
Deal Type Add-on Acquisition

Target

Impella CardioSystems AG

Aachen, Germany
Impella CardioSystems AG, develops, manufactures and markets minimally invasive cardiovascular support systems for numerous indications in the fields of cardiology and coronary surgery.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Abiomed

Danvers, Massachusetts, United States

Category Company
Founded 1981
Sector Medical Products
Employees1,725
Revenue 1.0B USD (2022)
DESCRIPTION

Abiomed is a cardiovascular device company. Abiomed develops, manufactures, and markets medical products designed to establish recovery's as the standard of care for acute patients. Abiomed was formed in 1981 and is based in Danvers, Massachusetts.


DEAL STATS #
Overall 1 of 4
Sector: Medical Products M&A 1 of 4
Type: Add-on Acquisition M&A Deals 1 of 4
Country: Germany M&A 1 of 2
Year: 2005 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-07-01 ECP Entwicklungsgesellschaft mbH

Berlin, Germany

ECP Entwicklungsgesellschaft mbH is a medical device company. ECP is developing a product that is a percutaneous, expandable catheter pump which increases blood circulation from the heart with an external drive shaft.

Buy $13M